Blawg Search - Law Blogs, Lawyer Blogs, Legal Blogs Directory & Search Engine

... the bandwagon (so what if it's a mixed metaphor?) here, to discuss Copley v. Wyeth, Inc., 2009 WL 1089663 (E.D. Pa. Apr. 22, 2009). ... legislative history in the face of an otherwise perfectly clear and unambiguous statute"); Bolin v. SmithKline Beecham Corp., 2008 WL 3286973, supra, at *2 ("this Court agrees with ... ) requires that the forum defendant be 'joined and served' to preclude removal"); Vitatoe v. Mylan Pharmaceuticals, supra, 2008 WL 3540462. On the other side of the ledger, well, that's ...

... Prandin (Repaglinide) - US: Novo Nordisk files patent infringement suit against Mylan over its ANDA to manufacture generic Prandin (Patent Docs) Preos (Recombinant human ... likelihood of confusion between PREOS and PROTOS for osteoporosis medications: NPS Pharmaceuticals, Inc v Biofarma, Société Par Actions Simplifiée (Canadian Trademark ... injunction; motivation can prove obviousness based on structural similarity: Altana and Wyeth v Teva (Patent Baristas) Provigil (Modfinil) - US: Apotex files suit ...

... eukaryotic genome to yield hematopoietic cell lines: (Patent Docs), Wyeth v Impax Laboratories, Inc: 'Extended release formulation' and other terms defined in ANDA ... Natco appeals to Supreme Court from High Court decision on IPAB composition: (Generic Pharmaceuticals & IP) Insulin - Wockhardt's pre-grant opposition to Lilly's ... generic Seasonale: (IP Law360), Sular (Nisoldipine) - Sciele sues Mylan over ANDA filing: (Generic Pharmaceuticals & IP) Tarka (Trandolapril & Verapamil) - Sanofi ...

... too attenuated even to qualify as an Article III case or controversy in federal court, citing Rivera v. Wyeth-Ayerst Laboratories, 283 F.3d 315, 321 (5th Cir. 2002), ... Prohias II, gets into even jucier defenses, since it's more specific to the pharmaceutical industry. There, the court goes after the substantive law relating to the consumer fraud claims. ... .N.Y. 1998), to which we would add analogous Lanham Act precedent: Mylan Pharmaceuticals, Inc. v. Proctor & Gamble Co., 443 F. Supp.2d 453, ...

... "); and (even more frequently) in Lanham Act claims. E.g., Mylan Laboratories, Inc., v. Matkari, 7 F.3d 1130, 1139 (4th Cir. 1993 ... (E.D. Mo. 2002); see generally Schwarz Pharma, Inc. v. Breckenridge Pharmaceutical, Inc., 388 F. Supp.2d 967, 974-75 (E.D. ... se cannot create novel state tort duties. See, e.g., Perry v. S.N., 973 S.W.2d 301, 306 (Tex. 1998); ... drug and device field - have addressed this aspect of parallelism. The closest is Bruesewitz v. Wyeth, Inc., 508 F. Supp.2d 430 (E.D. Pa. 2007), ...

... claim construction practice to Jepson claim: General Atomics Diazyme Lab Division v Axis-Shield ASA: (Patent Docs), US: USPTO grants Jivan's ... Warner-Lambert: (Mallesons Stephen Jaques), Lybrel (Levonorgestrel/ethinyl estradiol) - US: Wyeth commences patent infringement proceedings against Sandoz to prevent launch of generic Lybrel ... threats of enforcement don't establish DJ jurisdiction: Impax Labs v Medicis Pharmaceutical: (Patent Appeal Tracer), Synagis (Palivizumab) - US: MedImmune settles patent ...

... genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP ... (Pregabalin) - US: Pfizer, Warner-Lambert and CP Pharmaceuticals file patent infringement suit against Mylan and Alphapharm in attempt to block generic Lyrica (GenericsWeb) ... cause irreparable harm, affirms denial of preliminary injunction: Altana Pharma & Wyeth v Teva (Patently-O) (SmartBrief) (Patent Docs) (GenericsWeb) Renvela (Sevelamer) ...

... v Dexcel-Pharma Ltd: (IPKat), Eloxatin (Oxaliplatin) - South Korean court dismisses Sanofi-Aventis' patent claims against generic Oxaliplatin maker Boryung Pharmaceutical ... Amphastar & Teva: (Patent Baristas), Lybrel (Levonorgestrel/Ethinyl estradiol) - US: Wyeth launches patent suit against Sandoz to block generic Lybrel: (GenericsWeb), Metabolite ... Uganda: High Court awards damages for inconvenience in counterfeit pens case: Bic v Wenbara: (Afro-IP) Australia New Australian IP news blog - IPRoo ...

... state law" would "flout, or at least undermine, congressional intent." Merrell Dow Pharmaceuticals, Inc. v. Thompson, 478 U.S. 804, 812 (1986); see Bexis' ... same federal standards verbatim is the same sort of "ingenious pleading" that courts such as Mylan Laboratories have already rejected in the Lanham context in cases where §337(a) fully applies. ... top everything off, as we've discussed, there are no "parallel" claims asserted in Wyeth v. Levine. Thus we don't expect the Supreme Court to address ...

... to invalidate Everett patent for prescription multivitamin due to lack of subject matter (Patent Docs) (Law360) US: Wyeth files suit against Intervet and Boeringer Ingelheim Vetmedica alleging infringement of patents covering treatment for ... ) - US: Abbott Lab's sues Mylan for infringement of two patents related to Kaletra (GenericsWeb) Oxycodone - US: CAFC finds oxycodone method obvious: Robert Chapman v Michael Casner (Law360) Prilosec (Omeprazole) - US: Dr Reddy's wins summary judgment of non ...